β¨ Health Notices
5114
NEW ZEALAND GAZETTE, No. 202
1 DECEMBER 2005
Health
Medicines Act 1981
Consent to the Distribution of New Medicines
Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:
Schedule
Product: Cefazolin Sandoz
Active Ingredient: Cephazolin sodium 1.048mg equivalent to cephazolin 1g
Dosage Form: Powder for injection
New Zealand Sponsor: Novartis New Zealand Limited Pharmaceutical Sector
Manufacturer: Sandoz GmbH, Kundl, Austria
Product: m-Cefazolin
Active Ingredient: Cephazolin sodium 1.048g equivalent to cephazolin 1g
Dosage Form: Powder for injection
New Zealand Sponsor: Multichem NZ Limited
Manufacturer: Laboratorio Reig Jofre SA, Sant Adria de Besos, Barcelona, Spain
Product: m-Cefazolin
Active Ingredient: Cephazolin sodium 524mg equivalent to cephazolin 500mg
Dosage Form: Powder for injection
New Zealand Sponsor: Multichem NZ Limited
Manufacturer: Laboratorio Reig Jofre SA, Sant Adria de Besos, Barcelona, Spain
Product: Sudafed PE Phenylephrine Sinus Day + Night Relief (Combination Product)
Active Ingredients: Paracetamol 500mg
Phenylephrine hydrochloride 5mg
Dosage Form: Tablet
Manufacturer: Pfizer Laboratories (Pty) Limited, Retreat, Cape Town, South Africa
Active Ingredients: Chlorpheniramine maleate 2mg
Paracetamol 500mg
Phenylephrine hydrochloride 5mg
Dosage Form: Tablet
Manufacturer: Pfizer Laboratories (Pty) Limited, Retreat, Cape Town, South Africa
New Zealand Sponsor: Pfizer Consumer Healthcare Div. of Pfizer New Zealand Limited
Product: Sudafed PE Phenylephrine Sinus + Allergy & Pain Relief
Active Ingredients: Chlorpheniramine maleate 2mg
Paracetamol 500mg
Phenylephrine hydrochloride 5mg
Dosage Form: Tablet
New Zealand Sponsor: Pfizer Consumer Healthcare Div. of Pfizer New Zealand Limited
Manufacturer: Pfizer Laboratories (Pty) Limited, Retreat, Cape Town, South Africa
Product: Sudafed PE Phenylephrine Sinus + Pain Relief
Active Ingredients: Paracetamol 500mg
Phenylephrine hydrochloride 5mg
Dosage Form: Tablet
New Zealand Sponsor: Pfizer Consumer Healthcare Div. of Pfizer New Zealand Limited
Manufacturer: Pfizer Laboratories (Pty) Limited, Retreat, Cape Town, South Africa
Dated this 28th day of November 2005.
DON MATHESON, Deputy Director-General, Public Health (pursuant to delegation given by the Minister of Health on 6 July 2001).
go8098
Misuse of Drugs Act 1975
Medical Practitioner Who May Prescribe, Administer or Supply Controlled Drugs for the Purpose of Treating People With Drug Dependence
Pursuant to section 24 (7) (a) of the Misuse of Drugs Act 1975, I, Jeremy John Skipworth, acting under delegated authority from the Minister of Health, specify that
Dr David Alexander Ritchie, Novalis House, 275 Fifield Terrace, Waltham, Christchurch
is a medical practitioner who may prescribe, administer or supply controlled drugs for the purposes of that section.
Dated at Wellington this 22nd day of November 2005.
DR JEREMY SKIPWORTH, Deputy Director of Mental Health.
go7927
Next Page →
Online Sources for this page:
VUW Te Waharoa —
NZ Gazette 2005, No 202
Gazette.govt.nz —
NZ Gazette 2005, No 202
β¨ LLM interpretation of page content
π₯ Consent to the Distribution of New Medicines
π₯ Health & Social Welfare28 November 2005
Medicines Act 1981, New Medicines, Distribution Consent, Cefazolin, Sudafed
- DON MATHESON, Deputy Director-General, Public Health
π₯ Medical Practitioner Authorised to Prescribe Controlled Drugs
π₯ Health & Social Welfare22 November 2005
Misuse of Drugs Act 1975, Controlled Drugs, Medical Practitioner, Drug Dependence
- David Alexander Ritchie (Doctor), Authorised to prescribe controlled drugs
- DR JEREMY SKIPWORTH, Deputy Director of Mental Health